STAT

SEPTEMBER 5, 2023

University of California graduate students were thrilled last December when they won what they thought were big pay increases after an unprecedented strike. Most of them could expect a 10% salary increase the first year of the new three-year contract, the university system said. But students contend it hasn’t worked out that way. Graduate students on some of the academic system’s 10 campuses are accusing their universities of wage theft, claiming they’re using sleight of han

Documentation 145

Documentation 145

Pharmacy Times

SEPTEMBER 5, 2023

Tune in to this episode to gain a comprehensive understanding of the evolving role of pharmacists in Michigan's health care system, the potential benefits for patients, and how this paves the way for other states.

Vaccines 132

Vaccines 132

STAT

SEPTEMBER 5, 2023

More and more people, especially early career workers , want jobs fighting climate change. But when we think about climate work, we tend to imagine only a small number of activities, like integrating renewables into the grid or planning cities to be resilient against flooding and fires. We often overlook jobs in another key climate technology sector: biotechnology.

Vaccines 143

Vaccines 143

Pharmacy Times

SEPTEMBER 5, 2023

Manufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.

Insurance 123

Insurance 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 5, 2023

Health care leaders and technology companies are investing heavily in large language models, a powerful class of deep learning models that are trained on vast troves of data. But while enthusiasm for generative AI is high and research is booming, it’s just starting to gain a toehold in clinical settings. Generative AI could be a revolution in health care — but along the way, it will have to address concerns about whether tools meet standards of safety, privacy, equity, and practica

Hospitals 142

Hospitals 142

Fierce Healthcare

SEPTEMBER 5, 2023

Individuals appointed to positions in the Department of Health and Human Services (HHS) across the past three administrations often came from or departed for positions in the private sector, a tren | Offices like the CDC and CMS see many more appointees of different career backgrounds leaving for the private sector, a trend that researchers say deserves greater scrutiny to ensure agency decision-making is not being compromised.

124

124

Fierce Pharma

SEPTEMBER 5, 2023

Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act (IRA). | Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act. The case was filed Friday in New Jersey federal court, three days after the CMS revealed that Novartis’ heart failure treatment Entresto was among 10 drugs subject to price negotiations in 2026.

121

121

STAT

SEPTEMBER 5, 2023

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO. The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl

133

133

Fierce Healthcare

SEPTEMBER 5, 2023

Following a discrimination lawsuit in December against Blue Cross and Blue Shield of North Carolina, the state’s largest insurer has removed 48 drugs from its costliest drug tiers. | A lawsuit against Blue Cross and Blue Shield of North Carolina appears to have prompted the insurer to backtrack and remove 48 HIV drugs from its costliest drug tiers.

Insurance 118

Insurance 118

STAT

SEPTEMBER 5, 2023

Everyone has things that, looking back, they would have done differently in the early days of 2020, had they known how the Covid-19 pandemic would tear across the globe. But those regrets may be particularly poignant for global leaders whose actions (or lack thereof) had direct impacts on how Covid-19 spread. Joanne Liu, a professor at McGill University’s School of Population and Global Health and former international president of Doctors Without Borders, has some advice for those leaders

133

133

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

SEPTEMBER 5, 2023

Self-insured employers pay more for a host of medical procedures than fully insured employers, and just why should be investigated by policymakers, according to a

Insurance 121

Insurance 121

STAT

SEPTEMBER 5, 2023

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that led to their approval — namely, that older adults were largely left out of them. Among adults, RSV poses the biggest threat to the oldest seniors and people with certain preexisting health conditions.

Vaccines 131

Vaccines Nursing Homes 131

Fierce Pharma

SEPTEMBER 5, 2023

As the Federal Trade Commission (FTC) scrutinizes Pfizer’s $43 billion Seagen buyout, the antibody-drug conjugate (ADC) specialist has notched a phase 3 win that could broaden its cervical cancer a | The drug boosted overall survival, progression-free survival and objective response rates in patients with recurrent or metastatic cervical cancer who had disease progression on or after a front-line therapy.

115

115

STAT

SEPTEMBER 5, 2023

The term for a patient who lists their questions was likely coined in the late 19th century in the clinic of Jean-Martin Charcot at the Salpêtrière. Known as la maladie du petit papier , or the illness of the little paper, the derogatory descriptor was inherently feminine and usually reserved for hypochondriacs making a laundry list of their purported ailments.

Hospitals 123

Hospitals 123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Topics

SEPTEMBER 5, 2023

According to the Centers for Disease Control and Prevention, tens of thousands of HPV-related cancer diagnoses were given per year from 2015 to 2019.

98

98

STAT

SEPTEMBER 5, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

Hospitals 112

Hospitals 112

Fierce Healthcare

SEPTEMBER 5, 2023

The Centers for Medicare & Medicaid Services (CMS) is partnering with states to revamp regional healthcare delivery through the AHEA | Based on care models out of Maryland, Vermont and Pennsylvania, CMS is implementing the AHEAD Model to help states address chronic disease.

110

110

Fierce Pharma

SEPTEMBER 5, 2023

Despite scoring a number of federal contracts in recent years, it’s lights out for government-backed rescue autoinjector maker AktiVax. | AktiVax, also known as Aktiv Pharma Group, informed the state of Colorado that “the company must shut down substantially all of its operations,” citing “unexpected circumstances.” In turn, the company is mothballing three manufacturing facilities and laying off around 70 employees.

105

105

Fierce Healthcare

SEPTEMBER 5, 2023

Primary care physicians who become associated with health systems more often steer their patients toward the organization’s services, increasing both utilization and care spending, according to a s | Recent study data outline physicians' tendency to point patients toward their associated health system's specialists, EDs and hospitals after joining up.

Hospitals 110

Hospitals 110

Pharmaceutical Technology

SEPTEMBER 5, 2023

Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergenes Greer harma, concluding a year-long strategic review.

119

119

Drug Topics

SEPTEMBER 5, 2023

The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.

Immunization 98

Immunization 98

Pharmacy Times

SEPTEMBER 5, 2023

Understanding the virus protein’s insertion mechanisms can be useful in creating new COVID-19 vaccine targets.

Vaccines 123

Vaccines 123

Drug Store News

SEPTEMBER 5, 2023

The Buy with Prime app for Shopify is natively integrated into Shopify’s Checkout and admin, which aims to help merchants grow their business using Buy with Prime in their Shopify stores.

98

98

Pharmacy Times

SEPTEMBER 5, 2023

This year's survey features questions focused on compensation, fulfillment, and burnout.

132

132

Fierce Pharma

SEPTEMBER 5, 2023

CanSino Biologics' recent mRNA manufacturing tie-up with AstraZeneca represents just the tip of the iceberg, the company’s CEO has said. | After jumping into the mRNA game back in 2018, CanSino has built a facility in Shanghai that can produce up to 200 million vaccine doses a year, the company’s co-founder and CEO Xuefeng Yu told Reuters in a recent interview.

Vaccines 98

Vaccines 98

The Checkup by Singlecare

SEPTEMBER 5, 2023

When you or your child get a vaccine, it’s natural to wonder about possible side effects. The meningitis vaccine is recommended for pre-teens , teens, and specific high-risk individuals with certain health conditions. As with most vaccines, mild side effects are common after the meningitis vaccine. Your child may be asking, “Do meningitis shots hurt?

Vaccines 98

Vaccines Immunization Hospitals 98

ISPE

SEPTEMBER 5, 2023

Revolutionizing Biopharma Engineering: Key Takeaways from the 2023 Global Biopharma Engineering Forum and Ispe China Conference Trudy Patterson Tue, 09/05/2023 - 11:48 iSpeak Blog iSpeak Revolutionizing Biopharma Engineering: Key Takeaways from the 2023 Global Biopharma Engineering Forum and Ispe China Conference Qing Kevin Zhao 5 September 2023 Shanghai ISPE Pharmaceutical Information Company (SPIC) held the 2023 Global Biopharma Engineering Forum and ISPE China Conference in Hangzhou, China on

FDA 98

FDA 98

PharmaVoice

SEPTEMBER 5, 2023

Leaked data for Roche’s immunotherapy appeared positive, but some experts aren’t convinced it’ll make an impact for cancer patients.

105

105

European Pharmaceutical Review

SEPTEMBER 5, 2023

Novo Nordisk’s semaglutide injection Wegovy ® is now available as a treatment for obesity in the UK. The pharmaceutical company stated it believed that the launch of Wegovy will help provide an additional option to support people living with obesity in the UK. The semaglutide injection is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management.

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies Labelling 93

Drug Topics

SEPTEMBER 5, 2023

The 2023 Healthcare Advocate Summit is September 5 to 9 in New Orleans, Louisiana.

112

112

European Pharmaceutical Review

SEPTEMBER 5, 2023

The UK government is investing £5.5 million to establish a Medicines Manufacturing Skills Centre of Excellence. The centre will help the UK life sciences sector to have the right talent to drive innovation to support the UK in its response to future health emergencies. It will build on existing infrastructure and best practice, and deliver sustainable, end-to-end training provision.

Packaging 90

Packaging 90

Pharmacy Times

SEPTEMBER 5, 2023

AI is revolutionizing pharmacy practice by improving medication management, streamlining workflow, and enhancing patient safety and outcomes.

94

94

European Pharmaceutical Review

SEPTEMBER 5, 2023

Potential of real-time measurement through miniaturisation of a process analytical technology (PAT) technique has been reported in a Biotechnology and Bioengineering paper. A micromixer was able to effectively detect aggregation in offline measurement-validated samples. The authors described how a PAT fluorescent dye (FD)-based microfluidic sensor was successfully implemented in an integrated downstream process.

88

88

Drug Store News

SEPTEMBER 5, 2023

According to various reports, Kim Kardashian and Kylie Jenner are exploring buying back the stake in their respective businesses sold to Coty.

97

97